The activity of T cells is inhibited, leading to immune escaping of tumor cells through phosphatidylinositol 3-kinase (PI3K)/AKT serine/threonine kinase 1 (AKT)/mammalian target of rapamycin (mTOR) and other signaling pathways (10). This evidence concerns the gene AKT1 and neoplasm.